Abstract
Pancreaticobiliary maljunction (PBM) is a high-risk factor for biliary tract cancer. Because of the excessive length of the common channel in PBM, sphincter action does not directly affect the pancreaticobiliary junction, which allows pancreatic juice to reflux into the biliary tract. The refluxed pancreatic juice injures the epithelium of the biliary tract and promotes the development of the cancer. Indeed, a nationwide survey in Japan revealed that biliary cancers were detected in 21.6 and 42.4% of PBM patients with and without biliary dilatation, respectively. The mechanism of carcinogenesis in PBM is considered to be the “hyperplasia-dysplasia-carcinoma sequence” which differs from the usual biliary carcinogenesis (the “adenoma-carcinoma sequence” or “de novo carcinogenesis”) in the population without PBM. Hyperplastic changes of the biliary epithelium were observed even in children with PBM, and the Ki-67 labeling index was higher. Several gene mutations were reported to be related in biliary carcinogenesis of PBM.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Morine Y, Shimada M, Takamatsu H, Araida T, Endo I, Kubota M, et al. Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey. J Hepatobiliary Pancreat Sci. 2013;20(5):472–80.
Shimada K, Yanagisawa J, Nakayama F. Increased lysophosphatidylcholine and pancreatic enzyme content in bile of patients with anomalous pancreaticobiliary ductal junction. Hepatology. 1991;13(3):438–44.
Funabiki T, Sugiue K, Matsubara T, Amano H, Ochiai M. Bile acids and biliary carcinoma in pancreaticobiliary maljunction. Keio J Med. 1991;40(3):118–22.
Kozuka S, Tsubone N, Yasui A, Hachisuka K. Relation of adenoma to carcinoma in the gallbladder. Cancer. 1982;50(10):2226–34.
Watanabe H, Date K, Itoi T, Matsubayashi H, Yokoyama N, Yamano M, et al. Histological and genetic changes in malignant transformation of gallbladder adenoma. Ann Oncol. 1999;10(Suppl 4):136–9.
Tazuma S, Kajiyama G. Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. Langenbecks Arch Surg/Deutsche Gesellschaft fur Chirurgie. 2001;386(3):224–9.
Hanada K, Itoh M, Fujii K, Tsuchida A, Hirata M, Ishimaru S, et al. Pathology and cellular kinetics of gallbladder with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol. 1996;91(5):1007–11.
Yamamoto M, Nakajo S, Tahara E, Ito M, Taniyama K, Shimamoto F, et al. Mucosal changes of the gallbladder in anomalous union with the pancreatico-biliary duct system. Pathol Res Pract. 1991;187(2–3):241–6.
Tanno S, Obara T, Fujii T, Mizukami Y, Shudo R, Nishino N, et al. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer. 1998;83(2):267–75.
Tokiwa K, Ono S, Iwai N. Mucosal cell proliferation activity of the gallbladder in children with anomalous arrangement of the pancreaticobiliary duct. J Hepato-Biliary-Pancreat Surg. 1999;6(3):213–7.
Hanada K, Itoh M, Fujii K, Tsuchida A, Ooishi H, Kajiyama G. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer. 1996;77(3):452–8.
Matsubara T, Sakurai Y, Zhi LZ, Miura H, Ochiai M, Funabiki T. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction. J Hepato-Biliary-Pancreat Surg. 2002;9(3):312–21.
Funabiki T, Matsubara T, Miyakawa S, Ishihara S. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbecks Arch surg/Deutsche Gesellschaft fur. Chirurgie. 2009;394(1):159–69.
Matsubara T, Funabiki T, Jinno O, Sakurai Y, Hasegawa S, Imazu H, et al. p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. J Hepato-Biliary-Pancreat Surg. 1999;6(3):286–93.
Nagai M, Watanabe M, Iwase T, Yamao K, Isaji S. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. World J Surg. 2002;26(1):91–8.
Kamisawa T, Kuruma S, Chiba K, Tabata T, Koizumi S, Kikuyama M. Biliary carcinogenesis in pancreaticobiliary maljunction. J Gastroenterol. 2017;52(2):158–63.
Yamato T, Kurumaya H, Ohama K, Yamamichi N, Watanabe Y, Harada K, et al. Frequent expression of mucin core protein MUC1 in non-neoplastic gallbladder mucosa from patients with pancreaticobiliary maljunction. Liver. 1999;19(4):281–7.
Tsuchida A, Nagakawa Y, Kasuya K, Itoi T, Endo M, Ozawa T, et al. Immunohistochemical analysis of cyclooxygenase-2 and vascular endothelial growth factor in pancreaticobiliary maljunction. Oncol Rep. 2003;10(2):339–43.
Tsuchida A, Itoi T, Kasuya K, Endo M, Katsumata K, Aoki T, et al. Inhibitory effect of meloxicam, a cyclooxygenase-2 inhibitor, on N-nitrosobis (2-oxopropyl) amine induced biliary carcinogenesis in Syrian hamsters. Carcinogenesis. 2005;26(11):1922–8.
Ichikawa Y, Kamiyama M, Sekido H, Ishikawa T, Miura Y, Kamiya N, et al. Telomerase activity and Bcl-2 expression in gallbladders of pancreaticobiliary maljunction patients: a preliminary study. J Hepato-Biliary-Pancreat Surg. 2004;11(1):34–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yada, K., Mori, H., Ishibashi, H., Shimada, M. (2018). Carcinogenesis of Biliary Tract in Pancreaticobiliary Maljunction. In: Kamisawa, T., Ando, H. (eds) Pancreaticobiliary Maljunction and Congenital Biliary Dilatation. Springer, Singapore. https://doi.org/10.1007/978-981-10-8654-0_21
Download citation
DOI: https://doi.org/10.1007/978-981-10-8654-0_21
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8653-3
Online ISBN: 978-981-10-8654-0
eBook Packages: MedicineMedicine (R0)